Trupanion Inc (TRUP) Issues Quarterly Earnings Results
Trupanion Inc (NYSE:TRUP) posted its quarterly earnings results on Thursday. The financial services provider reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.03) by $0.04, Briefing.com reports. Trupanion had a net margin of 0.71% and a return on equity of 3.57%. The company had revenue of $63.12 million for the quarter, compared to analyst estimates of $61.44 million. During the same period in the prior year, the company earned ($0.06) earnings per share. The firm’s revenue was up 30.5% on a year-over-year basis.
Trupanion (NYSE:TRUP) traded up $3.47 during mid-day trading on Friday, hitting $31.52. 884,142 shares of the stock traded hands.
COPYRIGHT VIOLATION NOTICE: “Trupanion Inc (TRUP) Issues Quarterly Earnings Results” was reported by American Banking News and is owned by of American Banking News. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at https://www.americanbankingnews.com/2017/11/03/trupanion-inc-trup-issues-quarterly-earnings-results.html.
Several research firms have commented on TRUP. Canaccord Genuity upped their price target on shares of Trupanion from $28.00 to $29.00 and gave the company a “buy” rating in a report on Wednesday, August 2nd. Stifel Nicolaus reaffirmed a “buy” rating and issued a $24.00 price target (up from $18.00) on shares of Trupanion in a report on Wednesday, August 2nd. Royal Bank Of Canada upped their price target on shares of Trupanion from $19.00 to $26.00 and gave the company an “outperform” rating in a report on Wednesday, August 2nd. BidaskClub lowered shares of Trupanion from a “buy” rating to a “hold” rating in a report on Tuesday, August 8th. Finally, Cowen and Company reaffirmed an “outperform” rating and issued a $28.00 price target (up from $19.00) on shares of Trupanion in a report on Wednesday, August 2nd. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Trupanion has a consensus rating of “Buy” and an average target price of $27.50.
In related news, insider Darryl Rawlings sold 3,500 shares of the business’s stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $22.81, for a total transaction of $79,835.00. Following the sale, the insider now directly owns 1,456,505 shares in the company, valued at approximately $33,222,879.05. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Howard E. Rubin sold 100,000 shares of the company’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $25.90, for a total value of $2,590,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 134,000 shares of company stock worth $3,361,063.
Trupanion Company Profile
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
Receive News & Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related companies with MarketBeat.com's FREE daily email newsletter.